"Who cares if it wasn't?" That's hilarious.
Shall we go to FDA on the strength of the in-house?
A DB-RCT is the gold standard mate. It failed to validate your in-house study. Thus your sp is pus.
The market cares.
Any reputable scientific journal cares.
Heck, the whole medical community cares.
The only one who doesn't is you.
- Forums
- ASX - By Stock
- RAP
- Conference Call Summary
Conference Call Summary, page-459
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online